Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Apyx Medical Reports Preliminary FY23 Revenues Of ~$51.9M-$52.3M, Up 17%-18% Y/Y Versus Consensus Of $53.25M

Author: Benzinga Newsdesk | January 08, 2024 08:54am
  • Advanced Energy revenue in a range of approximately $43.1 to $43.5 million, representing growth of 17% to 18% year-over-year.
  • OEM revenue of approximately $8.8 million, representing growth of 14% year-over-year.

Posted In: APYX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist